Lisa E. Gralinksi

Statistics

Publications

Citations

598

H-Index

Active since

2020

Affiliations

Gilead Sciences (United States)(Current)

University of North Carolina at Chapel Hill

Vanderbilt University

Vanderbilt University Medical Center

Lisa E. Gralinksi is an author at Gilead Sciences (United States) specializing in viral therapeutic targets, antiviral agents, and antiviral therapeutics.

Publications per year

2020–2020

Publications

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · Cell Reports · 2020 · 540 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 36 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer et al. · SSRN Electronic Journal · 2020 · 22 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

1–3 of 3